Definition, epidemiology, and classification of diabetes in children and adolescents

Pediatric Diabetes

Volumn 15, Issue SUPPL.20, 2014, Pages 4-17

  Craig Prof , Maria E ^a,b   Jefferies, Craig ^c   Dabelea, Dana ^d   Balde, Naby ^e   Seth, Anju ^f   Donaghue, Kim C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^d Food Science and Human Nutrition   (United States)

^e University Hospital   (Guinea)

^f LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Adolescent; Child; Epidemiology; Type 1 diabetes

Indexed keywords

ADOLESCENT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; GLUCOSE INTOLERANCE; HEALTH; HEALTH CARE ORGANIZATION; HUMAN; INCIDENCE; INFANT; INSULIN RESISTANCE; INTERNATIONAL COOPERATION; MEDICINE; METABOLISM; PATHOPHYSIOLOGY; PEDIATRICS; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PREDIABETIC STATE; PRESCHOOL CHILD; TRENDS;

ADOLESCENT; ADOLESCENT MEDICINE; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; INDIVIDUALIZED MEDICINE; INFANT; INSULIN RESISTANCE; INTERNATIONAL AGENCIES; PEDIATRICS; PREDIABETIC STATE; SOCIETIES, SCIENTIFIC;

EID: 84906841019     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12186     Document Type: Article

References (152)

1. World Health Organisation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: World Health Organisation, 2006.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014: 37 (Suppl. 1): S81-S90.
3. Zeitler P, Fu J, Tandon N et al. Type 2 diabetes in the child and adolescent. Pediatr Diabetes 2014: 15 (Suppl. 20): 26-46.
4. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014: 37 (Suppl. 1): S14-S80.
5. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Geneva, Switzerland: World Health Organization, 2011.
6. Islam ST, Abraham A, Donaghue KC et al. Plateau of adiposity in Australian children diagnosed with type 1 diabetes: a 20-year study. Diabet Med 2014: 31: 686-690.
7. Kapellen TM, Gausche R, Dost A et al. Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database. J Pediatr Endocrinol Metab 2014: 27: 209-214.
8. Rewers A, Klingensmith G, Davis C et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 2008: 121: e1258-e1266.
9. Dabelea D, Rewers A, Stafford JM et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics 2014: 133: e938-e945.
10. Fendler W, Borowiec M, Baranowska-Jazwiecka A et al. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia 2012: 55: 2631-2635.
11. Irgens HU, Molnes J, Johansson BB et al. Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry. Diabetologia 2013: 56: 1512-1519.
12. Pihoker C, Gilliam LK, Ellard S et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab 2013: 98: 4055-4062.
13. Galler A, Stange T, Muller G et al. Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the Childhood Diabetes Registry of Saxony, Germany. Horm Res Paediatr 2010: 74: 285-291.
14. Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia 2009: 52: 8-16.
15. Barman KK, Premalatha G, Mohan V. Tropical chronic pancreatitis. Postgrad Med J 2003: 79: 606-615.
16. Watkins RA, Evans-Molina C, Blum JS, Dimeglio LA. Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review. Transl Res 2014: 164: 110-121.
17. Dabelea D, Pihoker C, Talton JW et al. Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care 2011: 34: 1628-1633.
18. Rubio-Cabezas O, Hattersley A, Njolstad P et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2014: 15 (Suppl. 20): 47-64.
19. Howson JM, Stevens H, Smyth DJ et al. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 2011: 60: 2635-2644.
20. Barrett JC, Clayton DG, Concannon P et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009: 41: 703-707.
21. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996: 59: 1134-1148.
22. Lambert AP, Gillespie KM, Thomson G et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004: 89: 4037-4043.
23. Nguyen C, Varney MD, Harrison LC, Morahan G. Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 2013: 62: 2135-2140.
24. Erlich H, Valdes AM, Noble J et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008: 57: 1084-1092.
25. Knip M. Pathogenesis of type 1 diabetes: implications for incidence trends. Horm Res Paediatr 2011: 76 (Suppl. 1): 57-64.
26. Aly TA, Ide A, Jahromi MM et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A 2006: 103: 14074-14079.
27. Steck AK, Wong R, Wagner B et al. Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR, DQ genotypes. Diabetes 2012: 61: 753-758.
28. Ziegler AG, Rewers M, Simell O et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013: 309: 2473-2479.
29. Bonifacio E, Krumsiek J, Winkler C, Theis FJ, Ziegler AG. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion. Acta Diabetol 2014: 51: 403-411.
30. DPT-1 Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002: 346: 1685-1691.
31. Verge CF, Gianani R, Kawasaki E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996: 45: 926-933.
32. Skyler JS, Krischer JP, Wolfsdorf J et al. Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial - type 1. Diabetes Care 2005: 28: 1068-1076.
33. Yeung G, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus - a systematic review of molecular studies. BMJ 2011: 342: d35.
34. Laitinen OH, Honkanen H, Pakkanen O et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 2014: 63: 446-455.
35. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009: 52: 1143-1151.
36. Dotta F, Censini S, van Halteren AG et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007: 104: 5115-5120.
37. Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 2013: 56: 185-193.
38. Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 2011: 343: d4092.
39. International Diabetes F. IDF Diabetes Atlas. 6th edn. Brussels, Belgium: International Diabetes F, 2013.
40. Diamond Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006: 23: 857-866.
41. Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA 2013: 310: 427-428.
42. Berhan Y, Waernbaum I, Lind T, Mollsten A, Dahlquist G, Swedish Childhood Diabetes Study Group. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011: 60: 577-581.
43. Skrivarhaug T, Stene LC, Drivvoll AK, Strom H, Joner G, Norwegian Childhood Diabetes Study Group. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 2014: 57: 57-62.
44. Rawshani A, Landin-Olsson M, Svensson AM et al. The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Diabetologia 2014: 57: 1375-1381.
45. Newhook LA, Penney S, Fiander J, Dowden J. Recent incidence of type 1 diabetes mellitus in children 0-14 years in Newfoundland and Labrador, Canada climbs to over 45/100, 000: a retrospective time trend study. BMC Res Notes 2012: 5: 628.
46. Ilonen J, Reijonen H, Green A et al. Geographical differences within finland in the frequency of HLA-DQ genotypes associated with type 1 diabetes susceptibility. Eur J Immunogenet 2000: 27: 225-230.
47. Kukko M, Virtanen SM, Toivonen A et al. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country. Diabetes Care 2004: 27: 676-681.
48. Tajima N, Morimoto A. Epidemiology of childhood diabetes mellitus in Japan. Pediatr Endocrinol Rev 2012: 10 (Suppl. 1): 44-50.
49. Zhao Z, Sun C, Wang C et al. Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997-2011. Acta Diabetol 2014: Apr 29. [Epub ahead of print] (PMID: 24777734).
50. Lin WH, Wang MC, Wang WM et al. Incidence of and mortality from type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PLoS One 2014: 9: e86172.
51. Park Y. Why is type 1 diabetes uncommon in Asia? Ann N Y Acad Sci 2006: 1079: 31-40.
52. Park YS, Wang CY, Ko KW et al. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum Immunol 1998: 59: 794-801.
53. Ikegami H, Fujisawa T, Kawabata Y, Noso S, Ogihara T. Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations. Ann N Y Acad Sci 2006: 1079: 51-59.
54. Sugihara S. Genetic susceptibility of childhood type 1 diabetes mellitus in Japan. Pediatr Endocrinol Rev 2012: 10 (Suppl. 1): 62-71.
55. Urakami T, Suzuki J, Yoshida A, Saito H, Mugishima H. Incidence of children with slowly progressive form of type 1 diabetes detected by the urine glucose screening at schools in the Tokyo metropolitan area. Diabetes Res Clin Pract 2008: 80: 473-476.
56. Urakami T, Yoshida A, Suzuki J et al. Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes. Diabetes Res Clin Pract 2009: 83: 89-93.
57. Imkampe AK, Gulliford MC. Trends in type 1 diabetes incidence in the UK in 0- to 14-year-olds and in 15- to 34-year-olds, 1991-2008. Diabet Med 2011: 28: 811-814.
58. Jarosz-Chobot P, Polanska J, Szadkowska A et al. Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetologia 2011: 54: 508-515.
59. Skordis N, Efstathiou E, Kyriakides TC et al. Epidemiology of type 1 diabetes mellitus in Cyprus: rising incidence at the dawn of the 21st century. Hormones (Athens) 2012: 11: 86-93.
60. Laron Z, Lewy H, Wilderman I et al. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J 2005: 7: 381-384.
61. Kahn HS, Morgan TM, Case LD et al. Association of type 1 diabetes with month of birth among U.S. youth: the SEARCH for Diabetes in Youth Study. Diabetes Care 2009: 32: 2010-2015.
62. Weets I, Kaufman L, Van der Auwera B et al. Seasonality in clinical onset of type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia 2004: 47: 614-621.
63. Wandell PE, Carlsson AC. Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden. Curr Diabetes Rev 2013: 9: 342-349.
64. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009: 373: 2027-2033.
65. Schober E, Waldhoer T, Rami B, Hofer S. Incidence and time trend of type 1 and type 2 diabetes in Austrian children 1999-2007. J Pediatr 2009: 155: 190-3 e1.
66. Haynes A, Bulsara MK, Bower C, Jones TW, Davis EA. Cyclical variation in the incidence of childhood type 1 diabetes in Western Australia (1985-2010). Diabetes Care 2012: 35: 2300-2302.
67. Derraik JG, Reed PW, Jefferies C, Cutfield SW, Hofman PL, Cutfield WS. Increasing incidence and age at diagnosis among children with type 1 diabetes mellitus over a 20-year period in Auckland (New Zealand). PLoS One 2012: 7: e32640.
68. Sipetic S, Maksimovic J, Vlajinac H et al. Rising incidence of type 1 diabetes in Belgrade children aged 0-14 years in the period from 1982 to 2005. J Endocrinol Invest 2013: 36: 307-312.
69. Bruno G, Maule M, Biggeri A et al. More than 20 years of registration of type 1 diabetes in Sardinian children: temporal variations of incidence with age, period of diagnosis, and year of birth. Diabetes 2013: 62: 3542-3546.
70. Lipman TH, Levitt Katz LE, Ratcliffe SJ et al. Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry. Diabetes Care 2013: 36: 1597-1603.
71. Tran F, Stone M, Huang CY et al. Population-based incidence of diabetes in Australian youth aged 10-18 yr: increase in type 1 diabetes but not type 2 diabetes. Pediatr Diabetes 2014: Mar 17. doi: 10.1111/pedi.12131. [Epub ahead of print].
72. Lawrence JM, Imperatore G, Dabelea D et al. Trends in incidence of type 1 diabetes among non-Hispanic White youth in the United States, 2002-2009. Diabetes 2014: Jun 4. pii: DB_131891. [Epub ahead of print].
73. Gyurus EK, Patterson C, Soltesz G. Twenty-one years of prospective incidence of childhood type 1 diabetes in Hungary - the rising trend continues (or peaks and highlands?). Pediatr Diabetes 2012: 13: 21-25.
74. Cinek O, Kulich M, Sumnik Z. The incidence of type 1 diabetes in young Czech children stopped rising. Pediatr Diabetes 2012: 13: 559-563.
75. Kraan JA, Claessen FMAP, Elliott KD et al. Population based incidence of type 1 diabetes in New South Wales Australia 1990-2010 - have we reached a plateau? (Oral Abstract). Pediatr Diabetes 2011: 12 (Suppl. 15): 25.
76. Hermann R, Knip M, Veijola R et al. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes - indication of an increased environmental pressure? Diabetologia 2003: 46: 420-425.
77. Gillespie KM, Bain SC, Barnett AH et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004: 364: 1699-1700.
78. Fourlanos S, Varney MD, Tait BD et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008: 31: 1546-1549.
79. Hemminki K, Li X, Sundquist J, Sundquist K. Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia 2009: 52: 1820-1828.
80. Parkkola A, Harkonen T, Ryhanen SJ, Ilonen J, Knip M. Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children. Diabetes Care 2012: 36: 348-354.
81. Olmos P, A'Hern R, Heaton DA et al. The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988: 31: 747-750.
82. Harjutsalo V, Podar T, Tuomilehto J. Cumulative incidence of type 1 diabetes in 10, 168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes 2005: 54: 563-569.
83. Steck AK, Barriga KJ, Emery LM, Fiallo-Scharer RV, Gottlieb PA, Rewers MJ. Secondary attack rate of type 1 diabetes in Colorado families. Diabetes Care 2005: 28: 296-300.
84. Gillespie KM, Aitken RJ, Wilson I, Williams AJ, Bingley PJ. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings. Diabetes 2014: 63: 1041-1047.
85. Gillespie KM, Gale EA, Bingley PJ. High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 2002: 51: 210-214.
86. Green A, Schober E, Christov V et al. Familial risk of type 1 diabetes in European children. Diabetologia 1998: 41: 1151-1156.
87. Dorman JS, Steenkiste AR, O'Leary LA, McCarthy BJ, Lorenzen T, Foley TP. Type 1 diabetes in offspring of parents with type 1 diabetes: the tip of an autoimmune iceberg? Pediatr Diabetes 2000: 1: 17-22.
88. El Hashimy M, Angelico MC, Martin BC, Krolewski AS, Warram JH. Factors modifying the risk of IDDM in offspring of an IDDM parent. Diabetes 1995: 44: 295-299.
89. Lorenzen T, Pociot F, Stilgren L et al. Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 1998: 41: 666-673.
90. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984: 311: 149-152.
91. Harjutsalo V, Lammi N, Karvonen M, Groop PH. Age at onset of type 1 diabetes in parents and recurrence risk in offspring. Diabetes 2010: 59: 210-214.
92. Tattersall R. Maturity-onset diabetes of the young: a clinical history. Diabet Med 1998: 15: 11-14.
93. Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 2011: 34: 1878-1884.
94. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001: 345: 971-980.
95. Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975: 24: 44-53.
96. Awa WL, Schober E, Wiegand S et al. Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database. Diabetes Res Clin Pract 2011: 94: 463-467.
97. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008: 4: 200-213.
98. Edghill EL, Dix RJ, Flanagan SE et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes 2006: 55: 1895-1898.
99. Iafusco D, Stazi MA, Cotichini R et al. Permanent diabetes mellitus in the first year of life. Diabetologia 2002: 45: 798-804.
100. Rubio-Cabezas O, Minton JA, Caswell R et al. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009: 32: 111-116.
101. Rubio-Cabezas O, Flanagan SE, Damhuis A, Hattersley AT, Ellard S. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr Diabetes 2012: 13: 322-325.
102. Rubio-Cabezas O, Edghill EL, Argente J, Hattersley AT. Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes. Diabet Med 2009: 26: 1070-1074.
103. Mohamadi A, Clark LM, Lipkin PH, Mahone EM, Wodka EL, Plotnick LP. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM. Pediatr Diabetes 2010: 11: 203-207.
104. Massa O, Iafusco D, D'Amato E et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 2005: 25: 22-27.
105. Iafusco D, Massa O, Pasquino B et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90, 000 live births. Acta Diabetol 2012: 49: 405-408.
106. von Muhlendahl KE, Herkenhoff H. Long-term course of neonatal diabetes. N Engl J Med 1995: 333: 704-708.
107. Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO, Shield JP. Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 2000: 49: 1359-1366.
108. Gardner RJ, Mackay DJ, Mungall AJ et al. An imprinted locus associated with transient neonatal diabetes mellitus. Hum Mol Genet 2000: 9: 589-596.
109. Flanagan SE, Patch AM, Mackay DJ et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007: 56: 1930-1937.
110. Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord 2010: 11: 199-204.
111. Gloyn AL, Cummings EA, Edghill EL et al. Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel. J Clin Endocrinol Metab 2004: 89: 3932-3935.
112. Massa O, Iafusco D, D'Amato E et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 2005: 25: 22-27.
113. Colombo C, Porzio O, Liu M et al. Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 2008: 118: 2148-2156.
114. Edghill EL, Flanagan SE, Patch AM et al. Insulin mutation screening in 1, 044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008: 57: 1034-1042.
115. Polak M, Dechaume A, Cave H et al. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes 2008: 57: 1115-1119.
116. Støy J, Edghill EL, Flanagan SE et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 2007: 104: 15040-15044.
117. Garin I, Edghill EL, Akerman I et al. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci U S A 2010: 107: 3105-3110.
118. Njolstad PR, Sovik O, Cuesta-Munoz A et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001: 344: 1588-1592.
119. Rubio-Cabezas O, Ellard S. Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options. Horm Res Paediatr 2013: 80: 137-146.
120. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997: 15: 106-110.
121. Guillausseau PJ, Dubois-Laforgue D, Massin P et al. Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (maternally inherited diabetes and deafness or MIDD). Diabetes Metab 2004: 30: 181-186.
122. Laloi-Michelin M, Meas T, Ambonville C et al. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab 2009: 94: 3025-3030.
123. Reardon W, Ross RJ, Sweeney MG et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992: 340: 1376-1379.
124. van den Ouweland JM, Lemkes HH, Ruitenbeek W et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992: 1: 368-371.
125. Mazzaccara C, Iafusco D, Liguori R et al. Mitochondrial diabetes in children: seek and you will find it. PLoS One 2012: 7: e34956.
126. Rana M, Munns CF, Selvadurai H, Donaghue KC, Craig ME. Cystic fibrosis-related diabetes in children-gaps in the evidence? Nat Rev Endocrinol 2010: 6: 371-378.
127. Rana M, Munns CF, Selvadurai HC, et al. Increased detection of cystic-fibrosis-related diabetes in Australia. Arch Dis Child 2011: 96: 823-826.
128. Hameed S, Morton JR, Jaffe A et al. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care 2010: 33: 221-226.
129. Waugh N, Royle P, Craigie I et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol Assess 2012: 16 iii-iv, 1-179.
130. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009: 32: 1626-1631.
131. Moran A, Milla C, Ducret R, Nair KS. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 2001: 50: 1336-1343.
132. Moran A, Pillay K, Becker D, Acerini CL. Management of cystic fibrosis related diabetes in children and adolescents. Pediatr Diabetes 2014: 15 (Suppl. 20): 65-76.
133. Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 1991: 14 (Suppl. 4): 39-47.
134. Vestri HS, Maianu L, Moellering DR, Garvey WT. Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology 2007: 32: 765-772.
135. Pui CH, Burghen GA, Bowman WP, Aur RJ. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr 1981: 99: 46-50.
136. Drachenberg CB, Klassen DK, Weir MR et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999: 68: 396-402.
137. Al Uzri A, Stablein DM, Cohn A. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001: 72: 1020-1024.
138. Maes BD, Kuypers D, Messiaen T et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001: 72: 1655-1661.
139. First MR, Gerber DA, Hariharan S, Kaufman DB, Shapiro R. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation 2002: 73: 379-386.
140. Bobo WV, Cooper WO, Stein CM et al. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry 2013: 70: 1067-1075.
141. Amed S, Dean H, Sellers EA et al. Risk factors for medication-induced diabetes and type 2 diabetes. J Pediatr 2011: 159: 291-296.
142. Bhisitkul DM, Morrow AL, Vinik AI, Shults J, Layland JC, Rohn R. Prevalence of stress hyperglycemia among patients attending a pediatric emergency department. J Pediatr 1994: 124: 547-551.
143. Valerio G, Franzese A, Carlin E, Pecile P, Perini R, Tenore A. High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr 2001: 90: 618-622.
144. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ III, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 2009: 94: 1656-1664.
145. Saz EU, Ozen S, Simsek Goksen D, Darcan S. Stress hyperglycemia in febrile children: relationship to prediabetes. Minerva Endocrinol 2011: 36: 99-105.
146. Weiss SL, Alexander J, Agus MS. Extreme stress hyperglycemia during acute illness in a pediatric emergency department. Pediatr Emerg Care 2010: 26: 626-632.
147. Herskowitz RD, Wolfsdorf JI, Ricker AT et al. Transient hyperglycemia in childhood: identification of a subgroup with imminent diabetes mellitus. Diabetes Res 1988: 9: 161-167.
148. Schatz DA, Kowa H, Winter WE, Riley WJ. Natural history of incidental hyperglycemia and glycosuria of childhood. J Pediatr 1989: 115: 676-680.
149. Vardi P, Shehade N, Etzioni A et al. Stress hyperglycemia in childhood: a very high risk group for the development of type I diabetes. J Pediatr 1990: 117: 75-77.
150. Herskowitz-Dumont R, Wolfsdorf JI, Jackson RA, Eisenbarth GS. Distinction between transient hyperglycemia and early insulin-dependent diabetes mellitus in childhood: a prospective study of incidence and prognostic factors. J Pediatr 1993: 123: 347-354.
151. Bhisitkul DM, Vinik AI, Morrow AL et al. Prediabetic markers in children with stress hyperglycemia. Arch Pediatr Adolesc Med 1996: 150: 936-941.
152. Shehadeh N, On A, Kessel I et al. Stress hyperglycemia and the risk for the development of type 1 diabetes. J Pediatr Endocrinol Metab 1997: 10: 283-286.